EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Dupilumab as Therapeutic Option in Polysensitized Atopic Dermatitis Patients Suffering from Food Allergy

Alvise Sernicola iD, Emanuele Amore, Giuseppe Rizzuto, Alessandra Rallo, Maria Elisabetta Greco iD, Chiara Battilotti iD, Francesca Svara, Giulia Azzella, Steven Paul Nisticò iD, Annunziata Dattola iD, Camilla Chello, Giovanni Pellacani und 1 weitere

Nutrients · 2024

DOI: 10.3390/nu16162797 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nutrients, 2024. Verfasst von Alvise Sernicola und 12 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Unit, Department of Clinical Internal Anesthesiological and Cardiovascular Sciences, "Sapienza" University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Food Hypersensitivity, Dermatitis, Atopic, Immunoglobulin E. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IgE-mediated food allergy is characterized immunologically by a type 1 immune response triggered upon exposure to specific foods and clinically by a broad range of manifestations and variable severity. Our understanding of food allergy within the allergic march of atopic dermatitis (AD) is still incomplete despite the related risk of unpredictable and potentially severe associated reactions such as anaphylactic shock. The aim of this pilot study was to investigate the effects of dupilumab, an IL-4/IL-13 monoclonal antibody approved for AD, on the allergic sensitization profile of patients with AD and type 1 hypersensitivity-related comorbidities, including oral allergy syndrome, anaphylaxis, and gastrointestinal disorders. We conducted an observational pilot study with a longitudinal prospective design, enrolling 20 patients eligible for treatment with dupilumab. Laboratory exams for total serum IgE, specific IgE, and molecular allergen components were performed at baseline and after 16 weeks of therapy. Our results demonstrate a statistically significant decrease in molecular components, specific IgE for trophoallergens, and specific IgE for aeroallergens following treatment with dupilumab. We suggest that modulating type 2 immunity may decrease IgE-mediated responses assessed with laboratory exams and therefore could minimize allergic symptoms in polysensitized patients. Upcoming results of randomized controlled trials investigating dupilumab in food allergy are highly anticipated to confirm its potential effect in the treatment of IgE-mediated food allergies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedFood HypersensitivityDermatitis, AtopicImmunoglobulin EHumansFemaleMaleAdultPilot ProjectsMiddle AgedProspective StudiesAllergensYoung AdultLongitudinal StudiesTreatment Outcome

Stichwörter der Autor:innen

comorbiditydupilumabfood allergyimmunotherapy

Substanzen

dupilumabAntibodies, Monoclonal, HumanizedImmunoglobulin EAllergens

Autor:innen und Institutionen

  • Dermatology Unit, Department of Clinical Internal Anesthesiological and Cardiovascular Sciences, "Sapienza" University of Rome, 00161 Rome, Italy.
  • Dermatology Unit, Department of Medicine (DIMED), University of Padua, 35121 Padova, Italy.

ORCID-Profile: Alvise Sernicola, Maria Elisabetta Greco, Chiara Battilotti, Steven Paul Nisticò, Annunziata Dattola, Teresa Grieco

Zitieren

APA

Sernicola, A., Amore, E., Rizzuto, G., Rallo, A., Greco, M. E., Battilotti, C., Svara, F., Azzella, G., Nisticò, S. P., Dattola, A., Chello, C., Pellacani, G., & Grieco, T. (2024). Dupilumab as Therapeutic Option in Polysensitized Atopic Dermatitis Patients Suffering from Food Allergy. Nutrients. https://doi.org/10.3390/nu16162797

Vancouver

Sernicola A, Amore E, Rizzuto G, Rallo A, Greco ME, Battilotti C, et al. Dupilumab as Therapeutic Option in Polysensitized Atopic Dermatitis Patients Suffering from Food Allergy. Nutrients. 2024. doi:10.3390/nu16162797

BibTeX
@article{Sernicola2024,
  author = {Sernicola, Alvise and Amore, Emanuele and Rizzuto, Giuseppe and Rallo, Alessandra and Greco, Maria Elisabetta and Battilotti, Chiara and Svara, Francesca and Azzella, Giulia and Nisticò, Steven Paul and Dattola, Annunziata and Chello, Camilla and Pellacani, Giovanni and Grieco, Teresa},
  title = {Dupilumab as Therapeutic Option in Polysensitized Atopic Dermatitis Patients Suffering from Food Allergy},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16162797}
}
Kostenlos starten →